Patents by Inventor Bharath Kumar KANDADI MURALIDHARAN

Bharath Kumar KANDADI MURALIDHARAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED INTERVAL DOSING OF NATALIZUMAB
    Publication number: 20210188982
    Abstract: Provided herein, in some embodiments, are methods for reducing the risk of developing progressive multifocal leukemia in patients undergoing natalizumab therapy by switching to an extended interval dosing (EID) schedule.
    Type: Application
    Filed: October 25, 2018
    Publication date: June 24, 2021
    Inventors: Nolan Robert Campbell, Ih Chang, Bharath Kumar Kandadi Muralidharan, Ivan Alexandrov Nestorov
  • COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE AND OTHER CNS DISORDERS
    Publication number: 20200255530
    Abstract: The invention relates to methods of treating stroke comprising administration of a VLA-4 antagonist to a subject after the onset of the stroke, e.g., ischemic stroke (e.g., acute ischemic stroke) or hemorrhagic stroke (e.g., intracerebral hemorrhage), sub-arachnoid hemorrhage, or traumatic brain injury. Kits and articles of manufacture are also described herein.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 13, 2020
    Applicant: Biogen MA Inc.
    Inventors: Lahar R. MEHTA, Bharath Kumar KANDADI MURALIDHARAN, Jacob ELKINS, Ivan NESTOROV